Trial news

OCTOPUS is going strong into 2025 with 15 participants have been screened and 9 randomised for Analysis Stage 2 (AS2), bringing the total for both stages up to 409 participants randomised and 492 participants screened! Check out the table below to see how each site is doing as of 20-February-2025: Site Number Screened Number Randomised UCLH (London) 148 125 ...

Dr Emma Gray, the head of clinical Trials at the MS Society, was recently featured on a Naked Scientists' Science Podcast. This episode of the podcast focussed on multiple sclerosis (MS), with Dr Gray speaking about OCTOPUS. You can check out her feature by clicking here - Dr Gray comes in at 20:54. You can also read the full transcript of her interview on the Naked Scientist ...

  Happy New Year! It's a new year and OCTOPUS has opened up to a new stage! 9 Participants have been screened and 4 randomised for Analysis Stage 2 (AS2), bringing the total for both stages up to 388 participants randomised and 450 participants screened! Check out the table below to see how each site is doing as of 09-January-2025: Site Number Screened Number Rand ...

We have now reached and exceeded our target for Analysis Stage 1 (AS1) with 384 participants randomised! Many thanks to all the site staff participating in Octopus, everyone who has been screened and randomised and all those who are signed on to join Octopus as we move into Analysis Stage 2 (AS2)! Check out the table below to see how we have done now that AS1 has ended: ...

One of Octopus' Personal and Public Involvement representatives, Susan Scott, recently was featured in an episode of MS Society's Research dates. She discussed clinical trials; their hopes for the future of MS care; the Octopus trial and importance of patient involvement in trials like Octopus. You can watch the video below and check out more of MS Society's MS Research dates ...